Wednesday, February 10, 2016 5:03:55 AM
I finally had the opportunity to check out Protagenic Theraputics website. (I woke up at 0230 and can't go back to sleep.) The information contained therein seems rather promising, i.e.: 7 worldwide patents pending, naturally occurring neuropeptides, two of which are in preclinical trials.
I bought into ATRN back in October 2011 just before the run to $0.35. I, just like most you guys, have been kicking myself for not selling while ATRN was above $0.30, but instead I got greedy which resulted in harrowing anguish.
I am cheerfully anticipating this merger will be the proverbial light at the end of the tunnel; the great reward for our seemingly unwaivering patience. I pray that Protagenic is the ray of hope that pierces through the disturbing darkness that is our doubt.
We have been holding strong for too long. This coming Monday is when our belovedly hated A-train will finally leave the station. Perhaps the past five years has been the time required to upgrade our lowly steam-powered locomotive to a over powered nuclear maglev bullet train?
Get your tickets now because we are rolling out Monday and not looking back nor returning to this pathetic depot ever again!
Recent PTIX News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 07:29:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2023 08:50:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2023 10:18:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 09:02:39 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/02/2023 08:29:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/13/2023 04:48:45 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 07:29:32 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM